Drugs / 5 FLUOROURACYL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02842580 | Sep 2016 → Oct 2020 | colorectal neoplasm | Federation Francophone de Cancerologie Digestive | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 5 FLUOROURACYL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02842580 ↗ |
| Route | Intravenous | “The continuous 5FU is administered IV at a dose of 2400 mg/m² over 46 hr (D1 and D2).” NCT02842580 ↗ |